Skip to content
NCRI logo alt test Toggle Menu

Main Navigation

  • About us
    • Overview
    • Our Partners
    • Our Team
    • Our Trustees
    • Our Strategy
    • Jobs and Opportunities
  • How We Work
    • NCRI Groups
    • NCRI Networks
    • Proposal Guidance
    • Clinical Trials Units
    • Patients and Carers
    • Early Career Researchers
    • Cancer Research Database
  • Areas of Interest
    • Cancer and Covid-19
    • Health Data and AI
    • Immunotherapy and Immunology
    • Living with and Beyond Cancer
    • Pathology
    • Prevention and Early Diagnosis
    • Radiotherapy
  • News and Events
    • News
    • Events
    • Reports and Publications
Newsletter sign up

Case Study

Filter Posts By:

  • Areas of Interest
    • Cancer Research Funding
    • Clinical Research Delivery
    • COVID-19
    • Health Data and AI
    • Imaging
    • Immunotherapy & Immunology
    • Living With & Beyond Cancer
    • Pathology
    • Patient & Public Involvement
    • Prevention & Early Diagnosis
    • Radiotherapy
    • Training & Retention
  • Cancers
    • Bladder & Renal
    • Brain
    • Breast
    • Children
    • Colorectal
    • Gynaecological
    • Haematological
    • Head & Neck
    • Lung
    • Lymphoma
    • Prostate
    • Sarcoma
    • Skin
    • TYA
    • Upper Gastrointestinal
  • Content
    • Blog
    • Case Study
    • Interviews
    • News
    • Press Releases

Reset Filters

'

Identifying new treatment options for patients with rare cancers and targetable tumour alterations

'
05 January 2022

The DETERMINE study aims to use genetic testing to match children, teenagers and adults with rare cancers to existing targeted…

Read More

'

Using NCRI data to develop a blood cancer research strategy

'
20 September 2021

NCRI and Blood Cancer UK have used the NCRI Cancer Research Database (CaRD) to analyse the blood cancer funding landscape…

Read More

'

NCRI Group members challenging the status quo in brain tumour research

'
15 February 2021

Members of the NCRI Brain Group have published a position statement arguing that there is not enough evidence to support…

Read More

'

Using online symptom reporting to manage cancer symptoms

'
26 January 2021

A trial has found that cancer patients can benefit from regular online symptom reporting combined with a computer algorithm to…

Read More

'

Supporting the development of high-quality research by providing expert guidance

'
13 January 2021

NCRI’s proposals guidance helps investigators develop ideas for cancer research studies and progress them into applications ready for funding. Researchers…

Read More

'

Identifying lymphoma treatment response using molecular profiling

'
15 December 2020

Diffuse large B cell lymphoma (DLBCL) is an aggressive B cell malignancy and the most common type of non-Hodgkin lymphoma.…

Read More

'

Study identifies challenges in involving young people in research

'
30 November 2020

Evaluating specialist care for young people with cancer was identified as a research priority by the NCRI Teenage and Young…

Read More

'

Developing one of the most extensive global studies of lung cancer patients

'
01 November 2020

Despite many years of clinical research into lung cancer, the outcomes for patients diagnosed with the disease remain poor. Most…

Read More

'

Making informed decisions in the event of myeloma relapse

'
09 September 2020

Treating relapsed myeloma Around 5,700 people are diagnosed with myeloma in the UK each year. As there is no cure…

Read More

'

Establishing a resource for chronic lymphocytic leukaemia researchers

'
06 September 2020

Biobanks give researchers access to biological material and clinical data on a scale that individual researchers would not be able…

Read More

'

Accurate detection of prostate cancer and the crucial role of patient involvement

'
27 May 2020

The Prostagram trial investigated the use of MRI scans to detect prostate cancer. At present, there is no nationally approved…

Read More

'

Could drug treatment combined with targeted radiotherapy improve brain mets prognosis?

'
24 March 2020

Patients with brain metastases are an underserved population Brain metastases occur in 20-40% of all patients with cancer. Brain metastases…

Read More

Posts navigation

  • 1
  • 2
  • 3
  • »

National Cancer Research Institute (NCRI)

2 Redman Place London E20 1JQ
T: +44 (0)20 3469 8798
E: info@ncri.org.uk

NCRI is a Charitable Incorporated Organisation (registered charity number: 1160609)

  • Terms and Conditions
  • Privacy Policy
  • Newsletter